BRL29060A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BRL29060A, covering 2009-11-19 to 2009-11-19. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD) [Phase 2]